2-(5-Tetrazolyl)pyridine - CAS 33893-89-9
Catalog: |
BB021886 |
Product Name: |
2-(5-Tetrazolyl)pyridine |
CAS: |
33893-89-9 |
Synonyms: |
2-(2H-tetrazol-5-yl)pyridine; 2-(2H-tetrazol-5-yl)pyridine |
IUPAC Name: | 2-(2H-tetrazol-5-yl)pyridine |
Description: | 2-(5-Tetrazolyl)pyridine (CAS# 33893-89-9) is a useful research chemical compound. |
Molecular Weight: | 147.14 |
Molecular Formula: | C6H5N5 |
Canonical SMILES: | C1=CC=NC(=C1)C2=NNN=N2 |
InChI: | InChI=1S/C6H5N5/c1-2-4-7-5(3-1)6-8-10-11-9-6/h1-4H,(H,8,9,10,11) |
InChI Key: | LQWXEEDCMLEVHU-UHFFFAOYSA-N |
Boiling Point: | 377.1 °C at 760 mmHg |
Density: | 1.388 g/cm3 |
Solubility: | 10.3 [ug/mL] (The mean of the results at pH 7.4) |
MDL: | MFCD00068114 |
LogP: | 0.26170 |
Publication Number | Title | Priority Date |
US-2021205311-A1 | Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 Inhibitors | 20200103 |
US-2021230294-A1 | Cd73 inhibitor and a2a/a2b adenosine receptor inhibitor combination therapy | 20200103 |
WO-2021138498-A1 | Cd73 inhibitor and a2a/a2b adenosine receptor inhibitor combination therapy | 20200103 |
WO-2021138512-A1 | Combination therapy comprising a2a/a2b and pd-1/pd-l1 inhibitors | 20200103 |
CN-110628421-A | Application of pyridine tetrazole tetranuclear copper [ I ] complex in stimulus response luminescent and photochromic material | 20191105 |
PMID | Publication Date | Title | Journal |
21837026 | 20110701 | Benzene-1,3,5-tricarb-oxy-lic acid-5-(pyridin-1-ium-3-yl)-5H-1,2,3,4-tetra-zol-5-ide (1/1) | Acta crystallographica. Section E, Structure reports online |
21522603 | 20101218 | Bromidotricarbon-yl[2-phenyl-5-(pyridin-2-yl-κN)-1,3,4-oxadiazole-κN]rhenium(I) dichloro-methane monosolvate | Acta crystallographica. Section E, Structure reports online |
21583337 | 20090704 | Bis[μ-5-(2-pyrid-yl)tetra-zolato]-κN,N:N;κN:N,N-bis-[triaqua-zinc(II)] bis-(trifluoro-acetate) monohydrate | Acta crystallographica. Section E, Structure reports online |
21583329 | 20090701 | Aqua-chloridobis[5-(2-pyrid-yl)-1H-tetra-zolato-κN]iron(III) | Acta crystallographica. Section E, Structure reports online |
21582333 | 20090311 | Diaqua-bis[5-(2-pyrid-yl)tetra-zolato-κN,N]iron(II) | Acta crystallographica. Section E, Structure reports online |
Complexity: | 128 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 147.05449518 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 147.05449518 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 67.4 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Triazole/Tetrazole
-
[1855888-97-9]
N-Benzyl-1-(1-ethyl-1H-1,2,4-triazol-5-yl)methanamine dihydrochloride
-
[6926-51-8]
5-(4-Methoxyphenyl)-2H-tetrazole
-
[828291-81-2]
5-(3-((2-Bromophenoxy)methyl)phenyl)-4-ethyl-4H-1,2,4-triazole-3-thiol
-
[1415314-22-5]
6-Chloro-8-iodo-[1,2,4]triazolo[1,5-a]pyridine
-
[1823442-03-0]
Ethyl 2-(3-bromo-1H-1,2,4-triazol-1-yl)butanoate
-
[1823402-86-3]
Ethyl 2-(3-bromo-1H-1,2,4-triazol-1-yl)propanoate
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS